ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,854, issued on March 4, was assigned to HELMHOLTZ ZENTRUM MUENCHEN-DEUTSCHES FORSCHUNGSZENTRUM FUERGESUNDHEIT UND UMWELT (GMBH) (Germany).
"TRAF 6 inhibitors" was invented by Kamyar Hadian (Munich), Jara Kerstin Brenke (Munich), Oliver Plettenburg (Ehlershausen, Germany), Gerrit Juerjens (Seelze, Germany) and Paul Wienecke (Hannover, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds which are suitable for the treatment of cancer, an immune disease, Parkinson's disease, Cardiac Hypertrophy or Type-2 diabetes and to pharmaceutical compositions containing such compounds. The invention further relates to a kit of ...